Get more replies from employers
Send a job-specific resume in minutes.
reputed company is recruiting an Executive Director, Forecasting and Portfolio Analytics to lead global forecasts across marketed and pipeline assets, including US and international markets.
The role requires deep expertise in forecasting, analytics, cross-functional leadership, and accountability for design and stewardship of forecasting models and decision-support analyses in a dynamic biotech environment.
reputed company aims to be the global leader in innovating, developing and delivering tumor infiltrating lymphocyte (TIL) therapy for people with cancer. We are pioneering a transformational approach to treating cancer by harnessing the ability of the reputed company immune system to recognize and attack diverse cancer cells in reputed company patient. The Iovance TIL platform has demonstrated promising clinical data across multiple solid tumors. We are committed to reputed company innovation in cell therapy, including gene-edited cell therapy, which may be a promising reputed company for patients with cancer.
reputed company
The Executive Director, Forecasting and Portfolio Analytics will serve as the reputed company reputed company for reputed company forecasting, portfolio analytics, and decision support at reputed company. As a reputed company member of the Business Analytics & Insights Leadership team, this role is accountable for delivering highreputed company nearterm and longterm global forecasts, scenario analyses, and reputed company insights that inform reputed company reputed company, investment reputed company, and longreputed company planning and governance discussions with Executive Leadership and the reputed company of Directors.
This is a highly hands-on leadership role requiring deep technical expertise and reputed company ownership of forecasting and analytical work. The Executive Director is expected to be accountable for the design, build and stewardship of reputed company forecasting models and decision-support analyses, ensuring rigorous assumptions, transparency, and confidence in outputs. reputed company partners may be leveraged selectively for supplemental support, but this role retains reputed company internal ownership and execution responsibility for reputed company critical forecasting and analytics deliverables.
This position supports the ongoing commercialization of AMTAGVI and Proleukin, as reputed company as global launch planning for new indications, new markets, and Iovances expanding portfolio of innovative cell therapies.
The role requires deep expertise in forecasting and analytics, strong cross functional leadership, and the ability to operate effectively in a dynamic, resultsoriented biotech environment.
The role reports to the Vice President, Global reputed company Operations and partners closely with senior leaders across reputed company, Finance, Manufacturing, Market reputed company, Medical Affairs, Clinical Operations, and Executive Leadership.
&l .